Karthik Ranganna
Overview
Explore the profile of Karthik Ranganna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee D, Boyle S, Malat G, Kern C, Milrod C, DeBellis S, et al.
Transpl Infect Dis
. 2017 Sep;
19(6).
PMID: 28921783
Human immunodeficiency virus (HIV)-infected patients have excellent outcomes following kidney transplantation (KT) but still might face barriers in the evaluation and listing process. The aim of this study was to...
12.
Boyle S, Malat G, Harhay M, Lee D, Pang L, Talluri S, et al.
Transpl Infect Dis
. 2017 May;
19(4).
PMID: 28520146
Background: Tenofovir disoproxil fumarate (TDF) is an antiretroviral agent frequently used to treat human immunodeficiency virus (HIV). There are concerns regarding its potential to cause acute kidney injury, chronic kidney...
13.
Philosophe B, Malat G, Soundararajan S, Barth R, Manitpisikul W, Wilson N, et al.
Clin Transplant
. 2014 Jun;
28(8):897-905.
PMID: 24931144
Predicting graft outcome after renal transplantation based on donor histological features has remained elusive and is subject to institutional variability. We have shown in a retrospective study that the Maryland...
14.
Malat G, Jindal R, Mehta K, Gracely E, Ranganna K, Doyle A
Transplantation
. 2014 Mar;
98(4):436-42.
PMID: 24621536
Introduction: We used the United Network of Organ Sharing Standard Transplant Analysis and Research Files (STAR files) to investigate the utility of the Kidney Donor Risk Index (KDRI) versus delayed...
15.
Malat G, Culkin C, Palya A, Ranganna K, Anil Kumar M
Drugs
. 2009 Oct;
69(15):2045-62.
PMID: 19791826
Among organ transplant recipients, the African American population historically has received special attention. This is because secondary to their disposition to certain disease states, for example hypertension, an African American...
16.
Mackelaite L, Alsauskas Z, Ranganna K
Med Clin North Am
. 2009 Jul;
93(4):855-69, viii.
PMID: 19577118
Renal failure in cirrhosis poses unique diagnostic and therapeutic challenges. Laboratory values and predictive equations grossly overestimate renal function in patients with cirrhosis. Development of renal failure connotes a worse...
17.
Anil Kumar M, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar A, et al.
Transpl Immunol
. 2008 Sep;
20(1-2):32-42.
PMID: 18773960
Induction and maintenance immunosuppression protocols with or without long-term steroid therapy in kidney transplant recipients are variable and are transplant center-specific. The aim of this prospective randomized pilot study was...
18.
Kode R, Fa K, Chowdhury S, Ranganna K, Fyfe B, Stabler S, et al.
Clin Transplant
. 2003 Jul;
17(4):369-76.
PMID: 12868995
Background: Current immunosuppressive therapies are very effective in preventing acute rejection (AR) and graft loss following renal transplantation. Newer agents now make it possible to develop equally efficacious but better...